Mark R. Pitzer

Preclinical Safety of RNAi-Mediated HTT Suppression in the Rhesus Macaque as a Potential Therapy for Huntington's Disease

Jodi L. McBride, Mark R. Pitzer, Ryan L. Boudreau et al. · Molecular Therapy · 2011 · 245 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Time Course of Apoptotic Cell Death within Mesencephalic Cell Suspension Grafts: Implications for Improving Grafted Dopamine Neuron Survival

Caryl E. Sortwell, Mark R. Pitzer, Timothy J. Collier · Experimental Neurology · 2000 · 145 citations

Life Sciences, Neurobiology, Neuroscience +17

A Clonal Line of Mesencephalic Progenitor Cells Converted to Dopamine Neurons by Hematopoietic Cytokines: A Source of Cells for Transplantation in Parkinson's Disease

Paul M. Carvey, Zao Dung Ling, Caryl E. Sortwell et al. · Experimental Neurology · 2001 · 142 citations

Life Sciences, Neurobiology, Neuroscience +17

Dopamine agonists and stress produce different patterns of Fos-like immunoreactivity in the lateral habenula

David Wirtshafter, Karen E. Asin, Mark R. Pitzer · Brain Research · 1994 · 142 citations

Life Sciences, Neurobiology, Neuroscience +17

Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington’s disease

Jodi L. McBride, Shilpa Ramaswamy, Mehdi Gasmi et al. · Proceedings of the National Academy of Sciences · 2006 · 102 citations · Full text

Life Sciences, Neurology, Neuroscience +17